
XWELL, Inc.
XWELNASDAQConsumer CyclicalPersonal Products & Services
Previous close
$1.04
+$0.1099 · +11.82%
XWEL company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
82
Deep Value
Momentum
30
Weakening
Sentiment
49
Mixed
Risk resilience
28
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteXWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. As of December 31, 2021, XWELL maintained a significant global presence, with 52 spa and clinic locations spanning 24 airports across the United States, the Netherlands, and the United Arab Emirates. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.
- Industry
- Personal Products & Services
- Sector
- Consumer Cyclical
- Headquarters
- US
- CEO
- Ezra T. Ernst
- Listed since
- Jul 27, 2010
- Employees
- 175
Market position
Day range
Current $1.04
52-week range
Current $1.04
- Open
- $0.9871
- Previous close
- $0.9301
- Volume
- 108.17K
- 0.92× average
- Average volume
- 117.16K
- Average daily volume
- Market cap
- 8.24M USD
- Beta
- 1.01
- Market reference 1
- 50-day average
- $1.0502
- -0.97% below average
- 200-day average
- $0.9679
- +7.45% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 11.41M USD
- P/E (TTM)
- -0.2×
- P/B (TTM)
- -4.46×
- P/S (TTM)
- 0.29×
- EV / EBITDA
- -0.81×
- Earnings yield
- -1104.35%
- Free cash flow yield
- -758.96%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 30.69%
- Operating margin
- -24.14%
- Net margin
- -82.81%
- Return on equity
- 77.10%
- Return on assets
- -151.48%
- Return on invested capital
- -247.71%
Financial health
- Debt / equity
- -3.93×
- Current ratio
- 0.46×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 29.21M USD | 33.9M USD | 30.11M USD | 55.94M USD | 73.73M USD |
| Cost of goods sold | 22.57M USD | 24.98M USD | 26.43M USD | 43.89M USD | 41.39M USD |
| Gross profit | 6.64M USD | 8.92M USD | 3.68M USD | 12.05M USD | 32.34M USD |
| Selling, general, and administrative | 16M USD | 20.08M USD | 20.91M USD | 31.17M USD | 24.2M USD |
| Operating expenses | 16M USD | 25.63M USD | 31.89M USD | 43.21M USD | 28.24M USD |
| Interest income | 661K USD | 380K USD | 448K USD | 384K USD | — |
| Interest expense | 134K USD | 179K USD | 321K USD | 462K USD | — |
| Depreciation and amortization | 1.78M USD | 938K USD | 3.55M USD | 5.43M USD | 3.2M USD |
| Operating income | −9.36M USD | −16.71M USD | −28.21M USD | −31.16M USD | 4.11M USD |
| Net income | −16.99M USD | −16.85M USD | −27.74M USD | −32.84M USD | 3.35M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 29%
- 2 beats, 4 misses, 1 met estimate
- Average EPS surprise
- -44.49%
- 7 comparable reports
- Latest EPS result
- -0.26
- Estimate -1 · Beat by 74.00%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
XWEL peers
ETFs holding XWEL
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research XWELresearch.disclaimer






